Flexible Doses of Niacin (Niaspan) as an Adjunct to Antipsychotic Medication in the Treatment of First Episode Psychosis

Last updated: November 1, 2011
Sponsor: Capital District Health Authority, Canada
Overall Status: Active - Recruiting

Phase

3

Condition

Schizotypal Personality Disorder (Spd)

Schizophrenia And Schizoaffective Disorders (Pediatric)

Brain Function

Treatment

N/A

Clinical Study ID

NCT01041053
HIM20091001
  • Ages 18-35
  • Both
  • Accepts Healthy Volunteers

Study Design

Total Participants: 90
Study Start date:
January 01, 2010
Estimated Completion Date:

Connect with a study center

  • Capital District Health Authority, NS Early Psychosis Program

    Halifax, Nova Scotia B3H 2E2
    Canada

    Active - Recruiting

  • Capital District Health Authority, NS Early PsychosisProgram

    Halifax, Nova Scotia B3H 2E2
    Canada

    Active - Recruiting

  • NS Early Psychosis Program

    Halifax, Nova Scotia B3H2E2
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.